Study: Aspirin cuts death risk in prostate cancer patients

10/25/2010 | WebMD

Preliminary results from a large study show that anti-coagulants, particularly aspirin, reduced the risk of death by more than 50% for men with prostate cancer that had not spread beyond the gland. Patients who took anti-coagulants were also less likely to experience cancer recurrence than those who didn't take such drugs.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC